Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
MEI Pharma revenue
MEI Pharma's revenue is $65.3 million.
What is MEI Pharma's revenue?
- MEI Pharma's revenue growth from 2003 to 2024 is 44,932.41%.
- MEI Pharma has 40 employees, and the revenue per employee ratio is $1,632,425.
- MEI Pharma's peak quarterly revenue was $65.3M in 2024(q1).
- MEI Pharma peak revenue was $65.3M in 2024.
- MEI Pharma annual revenue for 2023 was 48.8M, 19.95% growth from 2022.
- MEI Pharma annual revenue for 2024 was 65.3M, 33.76% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
MEI Pharma historical revenue
MEI Pharma's peak revenue was $65.3M in 2024. The peak quarterly revenue was $65.3M in 2024(q1).
MEI Pharma's revenue increased from $145.0k in 2003 to $65.3M currently. That's a 44,932.41% change in annual revenue.
MEI Pharma annual revenue
MEI Pharma annual revenue over time
| Fiscal year / year | MEI Pharma revenue |
|---|---|
| 2009 | ($2.0M) |
| 2010 | ($1.5M) |
| 2017 | $23.2M |
| 2018 | $1.6M |
| 2019 | $4.9M |
| 2020 | $27.8M |
| 2021 | $34.8M |
| 2022 | $40.7M |
| 2023 | $48.8M |
| 2024 | $65.3M |
How accurately did MEI Pharma's revenue projections match actual performance?
MEI Pharma annual growth
MEI Pharma saw the greatest revenue growth in 2020, when revenue increased by 464.72%.
MEI Pharma had the lowest revenue growth in 2017, when revenue changed by -1,649.93%.
MEI Pharma annual growth rate over time
| Year | MEI Pharma growth |
|---|---|
| 2009 | -397%↓ |
| 2010 | -25%↓ |
| 2017 | -1650%↓ |
| 2018 | -93%↓ |
| 2019 | 203%↑ |
| 2020 | 465%↑ |
| 2021 | 25%↑ |
| 2022 | 17%↑ |
| 2023 | 20%↑ |
| 2024 | 34%↑ |
MEI Pharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
MEI Pharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $96,000 | $76,000 | $29,000 | $27,063 |
| 2010 | $26,000 | - | - | - |
| 2017 | $1.1M | $17.2M | $4.5M | $449,000 |
| 2018 | $283,000 | $358,000 | $433,000 | $548,000 |
| 2019 | $488,000 | $2.0M | $1.2M | $1.1M |
| 2020 | $1.2M | $1.0M | $1.2M | $24.3M |
| 2021 | $6.6M | $12.6M | $8.1M | $7.5M |
| 2022 | $7.8M | $11.8M | $9.7M | $11.4M |
| 2023 | $8.7M | $32.7M | $5.9M | $1.5M |
| 2024 | $65.3M | - | - | - |
MEI Pharma jobs nearby
Do you work at MEI Pharma?
Did MEI Pharma meet its revenue projections?
MEI Pharma financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 40 |
| Date Founded | 2000 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $65.3M |
| Net Income | -$31,838,000 |
| Gross Proft | $33.4M (2021) |
| PE Ratio | 5.77 |
| Tax Rate | 0.0% |
| Market Capitalization | $102.5M |
| Total Assets | $120,809,000 |
| Ticker | MEIP |
MEI Pharma jobs you might like
MEI Pharma financing
MEI Pharma received early financing of $1.1M on 2011-05-31.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $1.1M | 05/2011 |
| Post Ipo Equity | $27.5M | 11/2012 |
| Post Ipo Equity | $5M | 07/2016 |
| Post Ipo Equity | $75M | 05/2018 |
| Post Ipo Equity | $51.8M | 12/2019 |
MEI Pharma investors
| Investors | Security type |
|---|---|
| Vivo Capital | Post Ipo Equity |
| Three Arch Partners | Post Ipo Equity |
| RA Capital Management | Post Ipo Equity |
| New Leaf Venture Partners | Post Ipo Equity |
| 3B Future Health Fund | Post Ipo Equity |
| New Enterprise Associates (NEA) | Post Ipo Equity |
| Vivo Capital | Post Ipo Equity |
| Perceptive Advisors | Post Ipo Equity |
| Biotechnology Value Fund | Post Ipo Equity |
| Amzak Health Investors | Post Ipo Equity |
| CAM Capital | Post Ipo Equity |
| Boxer Capital | Post Ipo Equity |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of MEI Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MEI Pharma. The employee data is based on information from people who have self-reported their past or current employments at MEI Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MEI Pharma. The data presented on this page does not represent the view of MEI Pharma and its employees or that of Zippia.
MEI Pharma may also be known as or be related to MEI PHARMA INC., MEI Pharma, MEI Pharma Inc, MEI Pharma, Inc. and Mei Pharma.